University of Basel
Overview
The University of Basel is a public research university in Switzerland that supports innovation through technology transfer, research grants, and an innovation office, though it is not a traditional investment firm.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MOMM Diagnostics | May 2022 | Seed | Co-investor |
| Cimeio Therapeutics | Apr 2022 | Series A | Co-investor |
| GlioCART GmbH | - | Grant | Co-investor |
| InCephalo Therapeutics | - | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is University of Basel based?
University of Basel is headquartered in Basel, Switzerland.
When was University of Basel founded?
University of Basel was founded in 1460.
How many portfolio companies does University of Basel have?
University of Basel has 4 portfolio companies in Caplight's dataset.
What are some companies in University of Basel's portfolio?
Portfolio companies visible on Caplight include MOMM Diagnostics, Cimeio Therapeutics, GlioCART GmbH, InCephalo Therapeutics.
What was University of Basel's most recent investment shown here?
University of Basel's most recent investment in this portfolio sample was in MOMM Diagnostics in 2022.
What sectors does University of Basel focus on?
University of Basel focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does University of Basel focus on?
Stage focus information for University of Basel is not publicly available.